Free National NPI Number Registry

Elina Blaha

Home > Elina Blaha

 

NPI Number Detailed Information

Provider Information:

Name: Elina Blaha
Gender: F
Provider License Number If Given: 601800141

NPI Information:

NPI: 1770582108
Entity Type
(Individual or Organization):
1-ind
Enumeration Date: 7/18/2005

Last Update Date: 1/30/2009

Reputation Report:

Provider Business Mailing Address:

Address: PO BOX 14292
Newport News, VA 23608
Phone Number: 7579888903
Fax Number: 7579888903

Provider Business Practice Location Address:

Address: 12407 JEFFERSON AVE SUITE A
Newport News, VA 23602
Phone Number: 7579888903
Fax Number: 7579888903

Provider Taxonomy:

Primary: 152WC0802X
Secondary (if any):
State: VA

Top Doctors in VA

 

About Elina Blaha

Elina Blaha ( ELINA BLAHA ) is The Optometrist Physician in Newport News, VA. The NPI Number for Elina Blaha is 1770582108.
The current location address for Elina Blaha is 12407 JEFFERSON AVE SUITE A Newport News, VA 23602 and the contact number is 7579888903 and fax number is 7579888903. The mailing address for Elina Blaha is PO BOX 14292 Newport News, VA 23608- 7579888903 (mailing address contact number - 7579888903).
The professional activities performed by an Optometrist related to the fitting of contact lenses to an eye, ongoing evaluation of the cornea's ability to sustain successful contact lens wear, and treatment of any external eye or corneal condition which can affect contact lens wear.

Provider Business Location on Map

FAQs:

What is the NPI Number for Elina Blaha ?


Answer: The NPI Number for Elina Blaha is 1770582108

Where is Elina Blaha located?


Answer: Elina Blaha is located at 12407 JEFFERSON AVE SUITE A Newport News, VA 23602.

What is the specialty for Elina Blaha ?


Answer: The Specialty of Elina Blaha is The Optometrist Physician.

Are there any online reviews for Elina Blaha ?


Answer: Yes! Check It Now.

Are there any other health care providers in Newport News, VA?


Answer: Yes, there are given below...

Medicare Physician & Other Practitioners

Information on services and procedures provided to Original Medicare (fee-for-service) Part B (Medical Insurance) beneficiaries by Elina Blaha

Number of HCPCS 13
Number of Medicare Beneficiaries 465
Number of Services 595
Total Submitted Charge Amount 83760
Total Medicare Allowed Amount 73272.82
Total Medicare Payment Amount 44731.35
Total Medicare Standardized Payment Amount 44677.42
Drug Suppress Indicator
Number of HCPCS Associated With Drug Services 0
Number of Medicare Beneficiaries With Drug Services 0
Number of Drug Services 0
Total Drug Submitted Charge Amount 0
Total Drug Medicare Allowed Amount 0
Total Drug Medicare Payment Amount 0
Total Drug Medicare Standardized Payment Amount 0
Medical Suppress Indicator
Number of HCPCS Associated With Medical Services 13
Number of Medicare Beneficiaries With Medical 465
Number of Medical Services 595
Total Medical Submitted Charge Amount 83760
Total Medical Medicare Allowed Amount 73272.82
Total Medical Medicare Payment Amount 44731.35
Total Medical Medicare Standardized Payment Amount 44677.42
Average Age of Beneficiaries 72
Number of Beneficiaries Age Less 65 24
Number of Beneficiaries Age 65 to 74 292
Number of Beneficiaries Age 75 to 84 118
Number of Beneficiaries Age Greater 84 31
Number of Female Beneficiaries 245
Number of Male Beneficiaries 220
Number of Non-Hispanic White Beneficiaries 337
Number of Black or African American Beneficiaries 76
Number of Asian Pacific Islander Beneficiaries 28
Number of Hispanic Beneficiaries
Number of American Indian/Alaska Native Beneficiaries
Number of Beneficiaries With Race Not Elsewhere Classified 12
Number of Beneficiaries With Medicare & Medicaid Entitlement 19
Number of Beneficiaries With Medicare Only Entitlement 446
Percent (%) of Beneficiaries Identified With Atrial Fibrillation 0.07
Percent (%) of Beneficiaries Identified With Alzheimer's Disease or Dementia 0.05
Percent (%) of Beneficiaries Identified With Asthma 0.06
Percent (%) of Beneficiaries Identified With Cancer 0.1
Percent (%) of Beneficiaries Identified With Heart Failure 0.1
Percent (%) of Beneficiaries Identified With Chronic Kidney Disease 0.23
Percent (%) of Beneficiaries Identified With Chronic Obstructive Pulmonary Disease 0.09
Percent (%) of Beneficiaries Identified With Depression 0.14
Percent (%) of Beneficiaries Identified With Diabetes 0.28
Percent (%) of Beneficiaries Identified With Hyperlipidemia 0.58
Percent (%) of Beneficiaries Identified With Hypertension 0.59
Percent (%) of Beneficiaries Identified With Ischemic Heart Disease 0.19
Percent (%) of Beneficiaries Identified With Osteoporosis 0.08
Percent (%) of Beneficiaries Identified With Rheumatoid Arthritis / Osteoarthritis 0.36
Percent (%) of Beneficiaries Identified With Schizophrenia / Other Psychotic Disorders
Percent (%) of Beneficiaries Identified With Stroke 0.05
Average HCC Risk Score of Beneficiaries 0.8685

Medicare Part D Prescribers

Information on prescription drugs provided to Medicare beneficiaries enrolled in Part D (Prescription Drug Coverage), by physicians and other health care providers, aggregated by provider.

Provider Specialty Type Optometry
Source of Provider Specialty
Number of Medicare Part D Claims, Including Refills 28
Number of Standardized 30-Day Fills 35.5
Aggregate Cost Paid for All Claims 4101.38
Number of Day's Supply for All Claims 682
Number of Medicare Beneficiaries 17
Number of Claims, Including Refills, for Beneficiaries Age 65+
Including Refills, for Beneficiaries Age 65+
Beneficiaries Age 65+
Number of Day's Supply for All Claims for Beneficaries Age 65+
Number of Medicare Beneficiaries Age 65+
Reason for Suppression of Brnd_Tot_Clms and Brnd_Tot_Drug_Cst
Total Claims of Brand-Name Drugs 15
Reason for Suppression of Gnrc_Tot_Clms and Gnrc_Tot_Drug_Cst
Total Claims of Generic Drugs, Including Refills 13
Aggregate Cost Paid for Generic Drugs 657.04
Reason for Suppression of Othr_Tot_Clms and Othr_Tot_Drug_Cst
Total Claims of Other Drugs, Including Refills 0
Aggregate Cost Paid for Other Drugs 0
Reason for Suppression of MAPD_Tot_Clmsand MAPD_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by MAPD Plans 11
Aggregate Cost Paid for Claims Filled by Beneficiaries in MAPD Plans 1967.16
Reason for Suppression of PDP_Tot_Clms and PDP_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by Standalone PDP Plans 17
Aggregate Cost Paid for Claims Filled by 2134.22
Reason for Suppression of LIS_Tot_Clms and LIS_Drug_Cst *
Number of Claims for Beneficiaries Covered by Low-Income Subsidy
Aggregate Cost Paid for Claims Covered by Low-Income Subsidy
Reason for Suppression of NonLIS_Tot_Clms and NonLIS_Drug_Cst #
Number of Claims for Beneficiaries Not Covered by Low-Income Subsidy
by Low-Income Subsidy
Total Claims of Opioid Drugs, Including 0
Aggregate Cost Paid for Opioid Drugs 0
Opioid Claims 0
Opioid_Tot_Clms divided by the Tot_Clms 0
Total Claims of Long-Acting Opioid Drugs 0
Aggregate Cost Paid for Long-Acting Opioid 0
Number of Day's Supply of All Long-Acting 0
Long-Acting Opioid Claims 0
Opioid_LA_Tot_Clms divided by the
Total Claims of Antibiotic Drugs, Including
Aggregate Cost Paid for Antibiotic Drugs
Antibiotic Claims
Reason for Suppression of Antpsyct_GE65_Tot_Clms and Antpsyct_GE65_Tot_Drug_Cst *
Including Refills, for Beneficiaries Age 65+
Aggregate Cost Paid for AntipsychoticDrugs for Beneficiaries Age 65+
Reason for Suppression of Antpsyct_GE65_Tot_Benes
Number of Medicare Beneficiaries Age 65+Filling Antipsychotic Claims
Average Age of Beneficiaries 73.411764706
Number of Beneficiaries Age Less Than 65
Number of Beneficiaries Age 65 to 74
Number of Beneficiaries Age 75 to 84
Number of Female Beneficiaries
Number of Male Beneficiaries
Number of Non-Hispanic White 13
Number of Black or African American
Number of Asian Pacific Islander 0
Number of Hispanic Beneficiaries
Number of American Indian/Alaskan NativeBeneficiaries 0
Number of Beneficiaries with Race Not 0
Only Entitlement
Average Hierarchical Condition Category 0.9808823529

More Providers in newport-news , va

elina blaha in Other Directories

Provider don't have other directory link yet.